Beacon Biosignals Acquires Dreem, Launches At-Home Sleep Monitoring Services For Clinical Trials
Acquiring Company
Beacon Biosignals
Acquired Company
Dreem
BostonInformation TechnologySoftwareDescription
Beacon Biosignals, the leading computational neurodiagnostics and electroencephalogram (EEG) analytics company, is pleased to announce that it has completed the acquisition of the research and development business of Dreem, a Paris-based pioneer in at-home sleep monitoring. This strategic acquisition signifies a remarkable milestone, setting the stage for clinical trial assessments at scale via the integration of Dreem's clinically-validated hardware with Beacon's next-generation EEG analytics platform.
Who to call at Beacon Biosignals, and when
When Beacon Biosignals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Beacon Biosignals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beacon Biosignals, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Biosignals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Dreem?
Dreem was acquired by Beacon Biosignals, based in Boston. The deal was reported on July 11, 2023. Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Beacon Biosignals is privately held and operates in Information Technology.
When did Beacon Biosignals acquire Dreem?
Beacon Biosignals's acquisition of Dreem was reported on July 11, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Dreem do?
Dreem Labs is a clinically validated, scalable sleep monitoring for clinical trials It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.